Mahaffey, KW;
Jardine, M;
Bompoint, S;
Cannon, C;
Bruce, N;
Herspink, LHJ;
Charytan, D;
... Perkovic, V; + view all
(2019)
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results From the Randomized CREDENCE Trial.
Circulation
, 140
(9)
pp. 739-750.
10.1161/CIRCULATIONAHA.119.042007.